Efficacy and Safety of the Anti–PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of the Anti–PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study

DOI Full Paper Access

27

Citations

23

References

2022

Year

Jusheng An, Jie Tang, Benjamin X. Li, Huihua Xiong, Hui Qiu, Lin Luo, Li Wang, Danbo Wang, Qi Zhou, Qin Xu,

Clinical Cancer Research

Abstract

Our study demonstrates that socazolimab has durable safety and efficacy for the treatment of recurrent or metastatic cervical cancer and exhibits a safety profile similar to other anti-PD-1/PD-L1 mAbs.

References

	Year	Citations

Page 1